首页> 外文期刊>Blood: The Journal of the American Society of Hematology >NOD2/CARD15 gene polymorphisms affect outcome in pediatric allogeneic stem cell transplantation.
【24h】

NOD2/CARD15 gene polymorphisms affect outcome in pediatric allogeneic stem cell transplantation.

机译:NOD2 / CARD15基因多态性影响小儿同种异体干细胞移植的结果。

获取原文
获取原文并翻译 | 示例
           

摘要

Distinct polymorphisms of NOD2/CARD15 (rs2066844 [SNP08], rs2066845 [SNP12], and rs2066847 [SNP13]) have influence on the incidence of Crohn disease (CD), a chronic inflammatory disorder of the gastrointestinal tract. Similar symptoms of CD and GVHD after allogeneic stem cell transplantation (allo-SCT) inspired Holler and coworkers to initiate a study that actually showed association of these polymorphisms and transplantation outcome. Subsequently some groups confirmed unfavorable association, whereas others did not. Because the impact of NOD2/CARD15 on SCT is still debatable, we initiated a retrospective multicenter study in pediatric patients (median age 9.8 years [0.2-21 years]) who received allo-SCT. The study was approved by the Goethe-University ethics committee (no. 294/05) and informed consent was obtained according to the Declaration of Helsinki. Genetic variants were analyzed in 567 donor-recipient pairs transplanted between 1996 and 2008. Of these, 446 were HLA-matched and 121 were mismatched.
机译:NOD2 / CARD15(rs2066844 [SNP08],rs2066845 [SNP12]和rs2066847 [SNP13])的明显多态性对克罗恩病(CD)的发病率有影响,克罗恩病是慢性胃肠道炎性疾病。同种异体干细胞移植(allo-SCT)后CD和GVHD的类似症状启发了Holler及其同事开展一项研究,该研究实际上表明了这些多态性与移植结果之间的关联。随后,一些团体确认了不利的联系,而其他团体则没有。由于NOD2 / CARD15对SCT的影响尚有争议,因此我们对接受allo-SCT的小儿患者(中位年龄9.8岁[0.2-21岁])开展了一项回顾性多中心研究。该研究得到了歌德大学伦理委员会的批准(第294/05号),并根据赫尔辛基宣言获得了知情同意。分析了1996年至2008年间移植的567个供体-受体对的遗传变异。其中446个与HLA匹配,而121个与错配。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号